{
    "organizations": [],
    "uuid": "99f3068b148affb08be7120137fca6f66482b810",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-inventiva-raises-capital-increase/brief-inventiva-raises-capital-increase-of-35-5-million-euros-idUSFWN1RP158",
    "ord_in_thread": 0,
    "title": "BRIEF-Inventiva Raises Capital Increase of 35.5 Million Euros",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 13 (Reuters) - Inventiva SA:\n* INVENTIVA RAISES â‚¬35.5 MILLION THROUGH A CAPITAL INCREASE WITH EUROPEAN AND US INVESTORS\n* INTENDS TO USE NET PROCEEDS FROM THIS CAPITAL INCREASE AS FOLLOWS\n* TO USE EUR 12 MILLION TO ENSURE CLINICAL DEVELOPMENT OF ODIPARCIL\n* TO USE NET PROCEEDS; EUR 3.5 MILLION TO ENSURE DEVELOPMENT OF ON-GOING DISCOVERY PROGRAMMES\n* EUR 16 MILLION TO ENSURE CLINICAL DEVELOPMENT OF LANIFIBRANOR\n* EXPECTED TO PROVIDE COMPANY WITH A CASH RUNWAY BASED ON ON-GOING PROGRAMMES TO MID-2020\n* ISSUED 5,572,500 NEW SHARES WITH A PAR VALUE OF EUR 0.01 AT A PRICE OF EUR 6.37 PER SHARE\n* AND WILL USE REMAINDER TO FINANCE OTHER CORPORATE PURPOSES\n* ISSUE PRICE OF NEW SHARES REPRESENTED A DISCOUNT OF 20% TO 3 DAY VOLUME WEIGHTED AVERAGE PRICE PRECEDING PRICING Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-13T14:35:00.000+03:00",
    "crawled": "2018-04-14T13:20:29.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "inventiva",
        "sa",
        "inventiva",
        "raise",
        "million",
        "capital",
        "increase",
        "european",
        "u",
        "investor",
        "intends",
        "use",
        "net",
        "proceeds",
        "capital",
        "increase",
        "follows",
        "use",
        "eur",
        "million",
        "ensure",
        "clinical",
        "development",
        "odiparcil",
        "use",
        "net",
        "proceeds",
        "eur",
        "million",
        "ensure",
        "development",
        "discovery",
        "programme",
        "eur",
        "million",
        "ensure",
        "clinical",
        "development",
        "lanifibranor",
        "expected",
        "provide",
        "company",
        "cash",
        "runway",
        "based",
        "programme",
        "issued",
        "new",
        "share",
        "par",
        "value",
        "eur",
        "price",
        "eur",
        "per",
        "share",
        "use",
        "remainder",
        "finance",
        "corporate",
        "purpose",
        "issue",
        "price",
        "new",
        "share",
        "represented",
        "discount",
        "day",
        "volume",
        "weighted",
        "average",
        "price",
        "preceding",
        "pricing",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}